Guillaume Martel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guillaume Martel has a total of 496 co-authors. Here are the top co-authors by number of shared publications:
- Timothy Michael Pawlik
Department of Surgery The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA
15 shared publications Irinel Popescu
Department of Surgery, Fundeni Clinical Institute , Bucharest
11 shared publicationsTori Lenet
Liver and Pancreas Unit, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada
11 shared publicationsDaniel I. McIsaac
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Anesthesiology and Pain Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
10 shared publicationsDean A. Fergusson
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
10 shared publicationsTom Hugh
Department of Surgery, The University of Sydney , Sydney, NSW
10 shared publications
Latest Publications
- 19 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (12) , 10022-10028
Surgeon Perspectives on Intraoperative Cell Salvage in Liver Resection for Cancer: A National Survey of Hepatopancreatobiliary Surgeons
- 19 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (12) , 10022-10028
Surgeon Perspectives on Intraoperative Cell Salvage in Liver Resection for Cancer: A National Survey of Hepatopancreatobiliary Surgeons
- 16 June 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (7)
Metastatic Lymph Node Burden and Invasive Tumour Features Inform First Recurrence Patterns After Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
Background: Recurrence is a major driver of poor long-term outcomes after curative-intent resection for intrahepatic cholangiocarcinoma (iCCA), yet the association between postoperative pathology, first recurrence patterns, and post-recurrence outcomes remains unclear. Methods: Patients who underwent curative-intent resection for iCCA (2000-2023) were identified from an international multi-institutional database. First recurrence patterns were classified as intrahepatic-only, extrahepatic-only, or combined intrahepatic and extrahepatic recurrence. Multivariable analyses assessed associations between postoperative pathologic features, first recurrence patterns, post-recurrence survival (PRS), and post-recurrence curative-intent treatment. Results: Among 1,328 patients, 57.5% (n=763) recurred; 717 had a classifiable first recurrence pattern (intrahepatic-only, n=381; extrahepatic-only, n=171; combined, n=165). Three or more metastatic lymph nodes (adjusted odds ratio [aOR] 3.47, 95%CI 1.56–7.72) and microvascular invasion (aOR 2.49, 95%CI 1.61–3.85) were associated with higher odds of combined recurrence compared with intrahepatic-only recurrence, whereas perineural invasion (aOR 2.24, 95%CI 1.35–3.71) and absence of pathologic nodal evaluation (aOR 2.04, 95%CI 1.24–3.36) were associated with extrahepatic-only recurrence. Compared with intrahepatic-only recurrence, combined recurrence was associated with worse PRS (adjusted hazard ratio 1.63, 95%CI 1.29–2.06) and lower odds of receiving curative-intent treatment (aOR 0.14, 95%CI 0.06–0.29). Conclusions: Pathologic nodal burden and invasive tumour features were associated with distinct first recurrence patterns after iCCA resection. Combined recurrence, more common with three or more metastatic lymph nodes or microvascular invasion, was associated with worse PRS and lower receipt of curative-intent treatment. Among patients who develop recurrence, postoperatively available pathological prognostic factors may help characterise first recurrence patterns and inform risk-adapted postoperative surveillance.
- 16 June 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (7)
Metastatic Lymph Node Burden and Invasive Tumour Features Inform First Recurrence Patterns After Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
Background: Recurrence is a major driver of poor long-term outcomes after curative-intent resection for intrahepatic cholangiocarcinoma (iCCA), yet the association between postoperative pathology, first recurrence patterns, and post-recurrence outcomes remains unclear. Methods: Patients who underwent curative-intent resection for iCCA (2000-2023) were identified from an international multi-institutional database. First recurrence patterns were classified as intrahepatic-only, extrahepatic-only, or combined intrahepatic and extrahepatic recurrence. Multivariable analyses assessed associations between postoperative pathologic features, first recurrence patterns, post-recurrence survival (PRS), and post-recurrence curative-intent treatment. Results: Among 1,328 patients, 57.5% (n=763) recurred; 717 had a classifiable first recurrence pattern (intrahepatic-only, n=381; extrahepatic-only, n=171; combined, n=165). Three or more metastatic lymph nodes (adjusted odds ratio [aOR] 3.47, 95%CI 1.56–7.72) and microvascular invasion (aOR 2.49, 95%CI 1.61–3.85) were associated with higher odds of combined recurrence compared with intrahepatic-only recurrence, whereas perineural invasion (aOR 2.24, 95%CI 1.35–3.71) and absence of pathologic nodal evaluation (aOR 2.04, 95%CI 1.24–3.36) were associated with extrahepatic-only recurrence. Compared with intrahepatic-only recurrence, combined recurrence was associated with worse PRS (adjusted hazard ratio 1.63, 95%CI 1.29–2.06) and lower odds of receiving curative-intent treatment (aOR 0.14, 95%CI 0.06–0.29). Conclusions: Pathologic nodal burden and invasive tumour features were associated with distinct first recurrence patterns after iCCA resection. Combined recurrence, more common with three or more metastatic lymph nodes or microvascular invasion, was associated with worse PRS and lower receipt of curative-intent treatment. Among patients who develop recurrence, postoperatively available pathological prognostic factors may help characterise first recurrence patterns and inform risk-adapted postoperative surveillance.
- 13 June 2026
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 40 (3) , 151009
Evaluating the Safety of Tranexamic Acid in Cancer Surgery: Clinical Evidence and Biological Rationale
- 13 June 2026
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 40 (3) , 151009
Evaluating the Safety of Tranexamic Acid in Cancer Surgery: Clinical Evidence and Biological Rationale
- Open Access
- 11 March 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
A scoping review of statistical methods for the analysis of method comparison studies with repeated measurements of clinical data
Background: Method comparison studies are conducted to examine the level of agreement between two instruments measuring physiological continuous parameters. The inclusion of repeated measurements in such studies poses additional challenges. The Bland & Altman limits of agreement (LOA) approach has been adapted to account for the correlation between repeated measurements and is widely used in method comparison studies. Alternate statistical methods are not always appropriate for the analysis of such data, and there is a paucity of evidence and guidelines pertaining to statistical methods that inform the analysis of method comparison studies that include repeated measurements. This scoping review aimed to identify methodological publications that propose statistical methods to inform the analysis of method comparison studies that include repeated measurements of continuous clinical data and that may be compared with the LOA method. Methods: Six online databases were searched from inception to November 2022 using a peer-reviewed search strategy. Searching of grey literature and books, as well as backward citation searching were performed to identify additional sources of evidence. Screening and data abstraction were done by two independent reviewers. Results were synthesized narratively. Results: Twenty-nine publications were included in this review. Thirty-two independent statistical methods were identified from the included publications, including variants of the LOA method. Four included publications compared findings from different versions of the LOA method. Four different approaches to handling repeated measurements in the context of method comparison studies were identified and were used to group findings from the included publications. Reported strengths and limitations of the LOA method were summarized. Conclusion: This scoping review provides a synthesis of existing statistical approaches to inform the analysis of method comparison studies with repeated measurements of clinical data, as well as how the various statistical methods perform when compared with various version of the LOA method. Based on the findings, it is generally advisable to consider using adjusted LOAs or modified mixed-effect LOAs in analyzing method comparison studies with repeated measurements. Trial registration: The protocol was registered on Open Science Framework ( https://osf.io/4p8ut ).
- 11 March 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Open AccessA scoping review of statistical methods for the analysis of method comparison studies with repeated measurements of clinical data
Background: Method comparison studies are conducted to examine the level of agreement between two instruments measuring physiological continuous parameters. The inclusion of repeated measurements in such studies poses additional challenges. The Bland & Altman limits of agreement (LOA) approach has been adapted to account for the correlation between repeated measurements and is widely used in method comparison studies. Alternate statistical methods are not always appropriate for the analysis of such data, and there is a paucity of evidence and guidelines pertaining to statistical methods that inform the analysis of method comparison studies that include repeated measurements. This scoping review aimed to identify methodological publications that propose statistical methods to inform the analysis of method comparison studies that include repeated measurements of continuous clinical data and that may be compared with the LOA method. Methods: Six online databases were searched from inception to November 2022 using a peer-reviewed search strategy. Searching of grey literature and books, as well as backward citation searching were performed to identify additional sources of evidence. Screening and data abstraction were done by two independent reviewers. Results were synthesized narratively. Results: Twenty-nine publications were included in this review. Thirty-two independent statistical methods were identified from the included publications, including variants of the LOA method. Four included publications compared findings from different versions of the LOA method. Four different approaches to handling repeated measurements in the context of method comparison studies were identified and were used to group findings from the included publications. Reported strengths and limitations of the LOA method were summarized. Conclusion: This scoping review provides a synthesis of existing statistical approaches to inform the analysis of method comparison studies with repeated measurements of clinical data, as well as how the various statistical methods perform when compared with various version of the LOA method. Based on the findings, it is generally advisable to consider using adjusted LOAs or modified mixed-effect LOAs in analyzing method comparison studies with repeated measurements. Trial registration: The protocol was registered on Open Science Framework ( https://osf.io/4p8ut ).
- Open Access
- 5 March 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (2)
Quality metrics for perioperative red blood cell transfusion in gastrointestinal cancer surgery: international Delphi consensus
Background: Perioperative red blood cell transfusion (RBCT) in gastrointestinal (GI) cancer surgery is associated with increased postoperative morbidity and higher healthcare costs. There are no standardized quality metrics to evaluate perioperative RBCT use. The aim of this study was to develop consensus-based quality metrics to assess and monitor perioperative RBCT in GI cancer surgery. Methods: A four-round Delphi process was conducted with 37 multidisciplinary international experts. After rating the importance of an initial list of possible metrics, panellists ranked them for priority and scored them for feasibility. Metrics were retained if rated as important and feasible. Consensus was defined as a median score between 4 and 5 and ≤ 22 panellists rating outside the score category containing the median. Results: Of 72 candidate metrics, 18 were retained after prioritization and feasibility scoring: five process, five outcome, and eight structure metrics. Process metrics included rate of perioperative RBCT at 3 days stratified by intraoperative and postoperative timing, and rate of RBCTs administered with haemoglobin > 7 g/dl, in patients undergoing GI cancer surgery. Outcome metrics included 30-day major morbidity and mortality, transfusion reactions, and patient-reported outcomes in patients receiving perioperative RBCT. Structure metrics addressed access to an on-site blood bank and the availability of institutional protocols for massive transfusion, anticoagulation reversal, and indications for perioperative RBCT. Conclusion: Through an international Delphi consensus, quality metrics were identified to support the monitoring of perioperative RBCT for GI cancer surgery. These metrics are important for quality monitoring, including institutional audits and performance assessment, to reduce variation in the use of RBCT, improve outcomes, and optimize blood product utilization.
- 5 March 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (2)
Open AccessQuality metrics for perioperative red blood cell transfusion in gastrointestinal cancer surgery: international Delphi consensus
Background: Perioperative red blood cell transfusion (RBCT) in gastrointestinal (GI) cancer surgery is associated with increased postoperative morbidity and higher healthcare costs. There are no standardized quality metrics to evaluate perioperative RBCT use. The aim of this study was to develop consensus-based quality metrics to assess and monitor perioperative RBCT in GI cancer surgery. Methods: A four-round Delphi process was conducted with 37 multidisciplinary international experts. After rating the importance of an initial list of possible metrics, panellists ranked them for priority and scored them for feasibility. Metrics were retained if rated as important and feasible. Consensus was defined as a median score between 4 and 5 and ≤ 22 panellists rating outside the score category containing the median. Results: Of 72 candidate metrics, 18 were retained after prioritization and feasibility scoring: five process, five outcome, and eight structure metrics. Process metrics included rate of perioperative RBCT at 3 days stratified by intraoperative and postoperative timing, and rate of RBCTs administered with haemoglobin > 7 g/dl, in patients undergoing GI cancer surgery. Outcome metrics included 30-day major morbidity and mortality, transfusion reactions, and patient-reported outcomes in patients receiving perioperative RBCT. Structure metrics addressed access to an on-site blood bank and the availability of institutional protocols for massive transfusion, anticoagulation reversal, and indications for perioperative RBCT. Conclusion: Through an international Delphi consensus, quality metrics were identified to support the monitoring of perioperative RBCT for GI cancer surgery. These metrics are important for quality monitoring, including institutional audits and performance assessment, to reduce variation in the use of RBCT, improve outcomes, and optimize blood product utilization.
- 5 February 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (7) , 2640-2655
Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
- 5 February 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (7) , 2640-2655
Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
- Open Access
- 2 December 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 582
Criteria used to define appropriate red blood cell transfusion in the perioperative setting: a scoping review
Intraoperative red blood cell (RBC) transfusion strategies vary depending on multiple factors. Several studies have documented significant variability in R
- 2 December 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 582
Open AccessCriteria used to define appropriate red blood cell transfusion in the perioperative setting: a scoping review
Intraoperative red blood cell (RBC) transfusion strategies vary depending on multiple factors. Several studies have documented significant variability in R
- 26 November 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (2) , 111309
Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC
- 26 November 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (2) , 111309
Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC
- 23 October 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 136 (1) , 237-246
Temporal trends in postoperative outcomes after major abdominal surgery: a population-based cohort study
- 23 October 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 136 (1) , 237-246
Temporal trends in postoperative outcomes after major abdominal surgery: a population-based cohort study
- 4 June 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (7) , 613-614
Hypovolaemic phlebotomy and bloodless liver surgery – Authors' reply
- 4 June 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (7) , 613-614
Hypovolaemic phlebotomy and bloodless liver surgery – Authors' reply